| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
59,362 |
52,698 |
$10.72M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
43,576 |
37,820 |
$10.47M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
27,543 |
23,010 |
$3.59M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
9,344 |
7,399 |
$3.32M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
6,406 |
5,303 |
$2.63M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,760 |
4,068 |
$2.10M |
| 70450 |
Computed tomography, head or brain; without contrast material |
9,096 |
6,979 |
$1.53M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,609 |
7,983 |
$1.09M |
| 71045 |
Radiologic examination, chest; single view |
22,780 |
16,847 |
$898K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12,410 |
10,609 |
$706K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,955 |
1,745 |
$652K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,661 |
11,133 |
$588K |
| C1776 |
Joint device (implantable) |
1,973 |
1,723 |
$567K |
| 71046 |
Radiologic examination, chest; 2 views |
9,557 |
8,210 |
$514K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,879 |
1,334 |
$490K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
21,177 |
18,406 |
$482K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,083 |
1,679 |
$477K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,858 |
2,492 |
$423K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
951 |
658 |
$375K |
| G0378 |
Hospital observation service, per hour |
4,025 |
3,011 |
$364K |
| 80053 |
Comprehensive metabolic panel |
58,010 |
40,305 |
$304K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,216 |
2,984 |
$287K |
| 72131 |
|
1,668 |
1,288 |
$281K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,982 |
2,588 |
$270K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,188 |
5,031 |
$264K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,221 |
2,042 |
$242K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
10,903 |
9,321 |
$235K |
| 85027 |
|
52,997 |
44,074 |
$208K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
10,022 |
7,725 |
$192K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
8,365 |
7,562 |
$180K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17,164 |
15,335 |
$160K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
279 |
217 |
$154K |
| 76830 |
Ultrasound, transvaginal |
1,344 |
1,217 |
$148K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,854 |
1,378 |
$141K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,817 |
1,678 |
$139K |
| 81025 |
|
19,046 |
17,236 |
$137K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
10,535 |
8,810 |
$121K |
| 76801 |
|
1,241 |
1,053 |
$118K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,034 |
1,201 |
$118K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,986 |
1,816 |
$116K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,276 |
2,846 |
$104K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
10,392 |
9,191 |
$98K |
| 84484 |
|
14,181 |
11,798 |
$96K |
| 93971 |
|
915 |
822 |
$95K |
| 85730 |
|
14,120 |
12,587 |
$83K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,993 |
8,160 |
$75K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
18,410 |
14,012 |
$72K |
| 74018 |
|
2,568 |
2,330 |
$72K |
| 81001 |
|
19,224 |
17,444 |
$70K |
| 87430 |
|
13,210 |
12,560 |
$67K |
| 73630 |
|
2,815 |
2,545 |
$65K |
| 83880 |
|
4,721 |
4,252 |
$64K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,889 |
1,670 |
$60K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
929 |
296 |
$59K |
| 73610 |
|
2,718 |
2,407 |
$59K |
| 64721 |
|
143 |
92 |
$58K |
| 88304 |
|
885 |
805 |
$57K |
| 96376 |
|
2,075 |
1,666 |
$56K |
| 73130 |
|
2,286 |
1,966 |
$54K |
| 36000 |
|
877 |
833 |
$53K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,501 |
2,274 |
$52K |
| 74022 |
|
1,272 |
1,215 |
$51K |
| 83690 |
|
17,069 |
15,297 |
$51K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,446 |
2,266 |
$51K |
| 73030 |
|
2,113 |
1,689 |
$51K |
| 73562 |
|
2,227 |
1,783 |
$50K |
| 81003 |
|
12,932 |
11,721 |
$49K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
225 |
197 |
$47K |
| 93975 |
|
290 |
265 |
$46K |
| 12001 |
|
364 |
337 |
$43K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
13,382 |
11,653 |
$40K |
| D7140 |
Extraction, erupted tooth or exposed root |
975 |
275 |
$39K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
539 |
468 |
$39K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
14 |
12 |
$38K |
| 85610 |
|
14,973 |
13,359 |
$38K |
| 72110 |
|
759 |
620 |
$36K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,109 |
2,521 |
$36K |
| 27447 |
|
12 |
12 |
$36K |
| 97161 |
|
1,191 |
902 |
$36K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,064 |
4,584 |
$35K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
1,999 |
377 |
$35K |
| 70486 |
|
231 |
201 |
$32K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
127 |
123 |
$29K |
| D3220 |
Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction |
783 |
310 |
$27K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
173 |
160 |
$27K |
| 87040 |
|
3,507 |
2,961 |
$27K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
583 |
500 |
$26K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
5,493 |
4,924 |
$25K |
| 73110 |
|
1,212 |
1,092 |
$24K |
| 85379 |
|
4,884 |
4,561 |
$23K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,808 |
3,213 |
$22K |
| 83735 |
|
6,191 |
5,443 |
$22K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,258 |
4,106 |
$22K |
| 87807 |
|
4,564 |
4,335 |
$21K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,571 |
1,434 |
$21K |
| 87081 |
|
8,080 |
7,500 |
$21K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,623 |
2,432 |
$20K |
| J3490 |
Unclassified drugs |
2,873 |
1,256 |
$19K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
6,170 |
4,885 |
$18K |
| 88312 |
|
672 |
607 |
$18K |
| 86900 |
|
4,472 |
3,595 |
$18K |
| 87088 |
|
4,818 |
4,388 |
$17K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,462 |
883 |
$17K |
| 87070 |
|
5,332 |
4,746 |
$17K |
| 83605 |
|
2,842 |
2,489 |
$16K |
| 84703 |
|
3,331 |
3,000 |
$15K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,609 |
1,329 |
$15K |
| C1769 |
Guide wire |
464 |
387 |
$15K |
| D3110 |
|
355 |
160 |
$14K |
| 86850 |
|
3,167 |
2,680 |
$13K |
| 87186 |
|
2,535 |
2,368 |
$13K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
156 |
150 |
$13K |
| 64447 |
|
108 |
105 |
$13K |
| 87077 |
|
3,178 |
2,807 |
$13K |
| 94664 |
|
990 |
868 |
$12K |
| C9399 |
Unclassified drugs or biologicals |
477 |
420 |
$12K |
| 84702 |
|
2,323 |
2,000 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
3,866 |
1,890 |
$12K |
| 73090 |
|
548 |
483 |
$12K |
| 10060 |
|
58 |
54 |
$11K |
| 12011 |
|
91 |
83 |
$11K |
| 80061 |
Lipid panel |
925 |
576 |
$10K |
| 90715 |
|
1,510 |
1,427 |
$10K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,290 |
1,128 |
$10K |
| 73080 |
|
447 |
410 |
$10K |
| D1351 |
Sealant - per tooth |
568 |
146 |
$10K |
| 73590 |
|
429 |
364 |
$10K |
| 87205 |
|
1,427 |
1,320 |
$9K |
| 71101 |
|
257 |
220 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,781 |
1,546 |
$8K |
| 73502 |
|
357 |
274 |
$8K |
| 86901 |
|
4,129 |
3,666 |
$8K |
| 82150 |
|
1,811 |
1,650 |
$7K |
| 72100 |
|
494 |
446 |
$7K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,140 |
2,045 |
$7K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,247 |
2,061 |
$7K |
| 80320 |
|
1,128 |
1,000 |
$7K |
| 74019 |
|
188 |
166 |
$6K |
| 86140 |
|
1,766 |
1,596 |
$6K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,208 |
1,103 |
$5K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
133 |
113 |
$5K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
21 |
12 |
$5K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
276 |
108 |
$5K |
| 82550 |
|
675 |
602 |
$5K |
| 72050 |
|
93 |
79 |
$5K |
| 73564 |
|
189 |
154 |
$5K |
| J2800 |
Injection, methocarbamol, up to 10 ml |
894 |
829 |
$4K |
| 84145 |
|
392 |
338 |
$4K |
| 70496 |
|
13 |
13 |
$4K |
| 72072 |
|
98 |
84 |
$4K |
| C2625 |
Stent, non-coronary, temporary, with delivery system |
18 |
15 |
$3K |
| 85651 |
|
1,013 |
951 |
$3K |
| 82077 |
|
635 |
586 |
$3K |
| 73700 |
|
18 |
12 |
$3K |
| 82803 |
|
256 |
219 |
$3K |
| 73140 |
|
109 |
95 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
302 |
176 |
$3K |
| 97165 |
|
72 |
62 |
$2K |
| D1208 |
Topical application of fluoride, excluding varnish |
110 |
67 |
$2K |
| 80074 |
|
59 |
58 |
$2K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
113 |
102 |
$2K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
101 |
84 |
$2K |
| J2060 |
Injection, lorazepam, 2 mg |
522 |
473 |
$2K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
231 |
199 |
$2K |
| 72040 |
|
75 |
71 |
$2K |
| 12002 |
|
13 |
12 |
$2K |
| 82553 |
|
207 |
183 |
$2K |
| 70498 |
|
12 |
12 |
$2K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
283 |
275 |
$2K |
| 72128 |
|
14 |
12 |
$2K |
| 80329 |
|
109 |
102 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,727 |
3,530 |
$1K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
409 |
382 |
$1K |
| 88307 |
|
13 |
12 |
$1K |
| D2740 |
Crown - porcelain/ceramic |
239 |
46 |
$1K |
| 29125 |
|
17 |
17 |
$1K |
| 93017 |
|
14 |
13 |
$1K |
| 29826 |
|
13 |
12 |
$1K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
29 |
25 |
$1K |
| 64415 |
|
29 |
25 |
$1K |
| A6223 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing |
38 |
33 |
$1K |
| C9113 |
Injection, pantoprazole sodium, per vial |
129 |
110 |
$1K |
| 36600 |
|
119 |
105 |
$945.85 |
| 76870 |
|
28 |
25 |
$932.62 |
| J1815 |
Injection, insulin, per 5 units |
548 |
321 |
$925.91 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
149 |
131 |
$904.50 |
| 84439 |
|
168 |
152 |
$715.47 |
| 86308 |
|
327 |
308 |
$697.41 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
16 |
13 |
$694.64 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
13 |
12 |
$685.19 |
| D3120 |
|
45 |
13 |
$637.32 |
| G0008 |
Administration of influenza virus vaccine |
27 |
25 |
$637.01 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
14 |
13 |
$608.44 |
| J2704 |
Injection, propofol, 10 mg |
437 |
417 |
$561.59 |
| 72170 |
|
17 |
14 |
$561.43 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
45 |
26 |
$536.46 |
| 73552 |
|
17 |
15 |
$470.40 |
| A9270 |
Non-covered item or service |
95 |
49 |
$458.42 |
| J1630 |
Injection, haloperidol, up to 5 mg |
195 |
184 |
$361.44 |
| J7050 |
Infusion, normal saline solution, 250 cc |
211 |
178 |
$338.83 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
194 |
175 |
$296.71 |
| 82607 |
|
13 |
12 |
$218.51 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
87 |
78 |
$210.01 |
| 82360 |
|
16 |
14 |
$167.31 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
43 |
40 |
$128.08 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
37 |
27 |
$127.19 |
| 82272 |
|
54 |
52 |
$109.81 |
| 86317 |
|
14 |
14 |
$108.19 |
| J0737 |
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
44 |
40 |
$100.38 |
| 84100 |
|
45 |
28 |
$97.26 |
| 97116 |
|
16 |
12 |
$78.95 |
| 84436 |
|
15 |
14 |
$76.48 |
| 80143 |
|
15 |
14 |
$70.92 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
13 |
12 |
$44.84 |
| J7999 |
Compounded drug, not otherwise classified |
270 |
247 |
$29.14 |
| 90686 |
|
17 |
13 |
$26.46 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
50 |
41 |
$23.65 |
| J3535 |
Drug administered through a metered dose inhaler |
60 |
53 |
$14.14 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
22 |
13 |
$9.97 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
13 |
12 |
$5.03 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
90 |
89 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
544 |
511 |
$0.00 |